[Effects of beta- and dimethyl beta-cyclodextrins on release and percutaneous absorption behaviors of prednisolone from some ointment bases].
Uekama
K
K
Masaki
K
K
Arimori
K
K
Irie
T
T
Hirayama
F
F
D000818:Animals; D003505:Cyclodextrins / Q000494:pharmacology*; D003912:Dextrins / Q000494:pharmacology*; D009824:Ointments; D011239:Prednisolone / Q000493:pharmacokinetics*; D011817:Rabbits; D012869:Skin Absorption / Q000187:drug effects*; D013213:Starch / Q000494:pharmacology*; D047392:beta-Cyclodextrins
D003505:Cyclodextrins; D003912:Dextrins; D009824:Ointments; D047392:beta-Cyclodextrins; C038119:heptakis(2,6-O-dimethyl)beta-cyclodextrin; D013213:Starch; D011239:Prednisolone; C031215:betadex